Latest News and Press Releases

Cannara expands its Curaleaf supply agreement to a potential C$34 million over two years, if fully realized, while supporting growth in Canada.

MONTRÉAL, 05 oct. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », la « Société », « nous » ou « notre ») (TSX : LOVE) (OTCQX : LOVFF) (FRA : 8CB0), un producteur verticalement...

Cannara expands its syndicated credit facility to $80 million with BMO and TD, increasing liquidity and extending maturity to December 2029.

MONTRÉAL, 10 sept. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », la « Société », « nous » ou « notre ») (TSX : LOVE) (OTCQX : LOVFF) (FRA : 8CB0), un producteur verticalement...

Cannara appoints Nicholas Fozard as Chief Financial Officer as Niko Sosiak transitions fully into his role as Chief Operating Officer.

MONTRÉAL, 01 sept. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») (TSX: LOVE) (OTCQX : LOVFF) (FRA : 8CB0), producteur verticalement intégré de cannabis...

Cannara establishes an automatic share purchase plan to buy common shares under its normal course issuer bid during regulatory blackout periods.

MONTRÉAL, 13 août 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») (TSX : LOVE) (OTCQX : LOVFF) (FRA : 8CB0), producteur verticalement intégré de...

Cannara announces a Normal Course Issuer Bid, reinforcing its disciplined capital allocation strategy and commitment to long-term shareholder value.

MONTRÉAL, 22 juill. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») (TSX : LOVE) (OTCQX : LOVFF) (FRA : 8CB0), producteur verticalement intégré de cannabis...